| Application no. and date | 16775340.9 (espacenet) (Federated) (European Patent Register), 20160927 | | Patent/reg. no. and date | DK/EP 3356329, 20200415 | | Publication date | 20180808 | | Priority no. and date | WO PCT/CN2015/091024, 20150929 | | EP pub. no. and date |
EP 3356329 20180808 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/161034 | | Inventor | LUSTENBERGER, Philipp, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
MATHES, Christian, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
FEI, Zhongbo, c/o SUZHOU NOVARTIS PHARMA TECHNOLOGY CO. LTD.
No. 18 Tonglian Road
Yanjiang Industrial Park
Economic Development Zone
Changshu City
Jiangsu 215537, CN,
RISS, Bernard, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
SCHLAMA, Thierry, c/o Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07D 213/74 (2006.01) , C07D 471/04 (2006.01) | | Title | Fremgangsmåde til fremstilling af 1-(4-methansulfonyl-2-trifluormethylbenzyl)-2-methyl-1H-pyrrolo[2,3-B]pyridin-3-yleddikesyre | | Int. application no. | IB2016055777 | | Int. publication no. | WO2017056001 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
